Alpha-cyclodextrin

DIETARY_SUPPLEMENT4 trials

Sponsors

Pennington Biomedical Research Center, Evgen Pharma, SFI Research, Mayo Clinic

Conditions

Cardiovascular DiseaseHealthy ParticipantsHealthy VolunteersObesityProstate Cancer

Phase 1

Sulforadex in Healthy Human Males MAD

CompletedNCT02055716

Evgen PharmaProstate Cancer

Start: 2014-01-31End: 2014-05-31Updated: 2015-02-10

Unknown Phase

The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion

WithdrawnNCT01910558

Pennington Biomedical Research CenterCardiovascular Disease, Obesity

Start: 2013-10-31End: 2013-10-31Updated: 2016-04-27

FBCx (Alpha-CD) Mechanism of Action Trial

CompletedNCT02999620

SFI ResearchHealthy Volunteers

Start: 2017-01-31End: 2017-07-31Updated: 2017-08-11

Determining Lipid Content in Stool After Alpha-cyclodextrin

CompletedNCT03002168

Mayo ClinicHealthy Participants

Start: 2017-01-20End: 2017-06-05Updated: 2017-11-17

Related Papers

A Randomised Controlled Trial of SFX-01 After Subarachnoid Haemorrhage — The SAS Study

Translational Stroke Research2024-07-196 citations

Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial

BMJ Open2020-03-0133 citations

The Soluble Fiber α-Cyclodextrin Does Not Increase the Fecal Losses of Dietary Fat in Adults-A Double-Blind, Randomized, Placebo-Controlled, Crossover Trial.

2018-09-014 citations